Prevalence of suicidal behavior in patients with chronic pain: a systematic review and meta-analysis of observational studies.

Chan-Young Kwon, Boram Lee
Author Information
  1. Chan-Young Kwon: Department of Oriental Neuropsychiatry, Dong-Eui University College of Korean Medicine, Busan, Republic of Korea.
  2. Boram Lee: KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea.

Abstract

Objective: Chronic pain is a leading cause of disability, severely impairing an individual's daily activity and quality of life. In addition, this condition may contribute to suicidal thoughts by leading to neuropsychological impairments, a perceived lack of meaning in life, and pain-related catastrophizing. This systematic review aimed to comprehensively investigate the prevalence and associated factors of suicidal behaviors (SBs) including suicidal ideation (SI) and suicide attempt (SA) or its complete, in individuals with chronic pain.
Methods: Five electronic databases were searched up to October 4, 2022. Only observational studies investigating the prevalence of SB in individuals with chronic pain were included. The methodological quality of the included studies was assessed using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. A meta-analysis was conducted to quantify the prevalence of SB in the population, and the command "Metaprop" was used in STATA/MP 16. In addition, factors explaining the association between chronic pain and SB identified through regression analysis were investigated.
Results: A total of 19 studies were included in this review ( = 3,312,343). The pooled lifetime prevalence of SI and SA was 28.90% (95% confidence interval, 17.95 to 41.26%) and 10.83% (5.72 to 17.30%), respectively, in a mixed sample comprising various chronic pain conditions. Importantly, the pooled prevalence of past 2-week SI was as high as 25.87% (18.09 to 34.50%). The methodological quality of the included studies was not optimal, and studies using validated SB assessment tools were lacking. Potential protective factors against SB in this population included pain coping and self-efficacy, older age, certain race/ethnicity groups, and marriage.
Conclusion: This systematic review and meta-analysis demonstrated the high prevalence of SB in individuals with chronic pain. Specifically, around 1 in 4 individuals with chronic pain had SI within the last 2 weeks. However, there was considerable heterogeneity in the pooled prevalence of SB in this population.

Keywords

References

  1. Scand J Public Health. 2019 Feb;47(1):9-17 [PMID: 29207932]
  2. J Clin Med. 2019 Jul 31;8(8): [PMID: 31370200]
  3. Pain. 2015 Jun;156(6):1003-1007 [PMID: 25844555]
  4. J Headache Pain. 2021 May 10;22(1):36 [PMID: 33971819]
  5. Psychol Serv. 2018 Aug;15(3):309-315 [PMID: 30080089]
  6. J Am Acad Child Adolesc Psychiatry. 2009 Oct;48(10):1005-1013 [PMID: 19730273]
  7. BMJ. 2019 Feb 6;364:l94 [PMID: 31339847]
  8. J Consult Clin Psychol. 1979 Apr;47(2):343-52 [PMID: 469082]
  9. Psychotherapy (Chic). 2022 Jun;59(2):174-180 [PMID: 34323576]
  10. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jul 13;93:284-290 [PMID: 31004724]
  11. JMIR Form Res. 2021 Jun 4;5(6):e29365 [PMID: 34003136]
  12. PLoS One. 2015 Mar 13;10(3):e0118961 [PMID: 25768737]
  13. J Pain. 2018 Jul;19(7):797-806 [PMID: 29526669]
  14. J Oral Facial Pain Headache. 2016 Fall;30(4):296-301 [PMID: 27792796]
  15. Prog Neurobiol. 2013 Oct;109:1-27 [PMID: 23827972]
  16. J Psychosom Res. 2022 Jun;157:110788 [PMID: 35334350]
  17. Clin J Pain. 2017 Aug;33(8):699-706 [PMID: 27768608]
  18. Focus (Am Psychiatr Publ). 2020 Apr;18(2):100-105 [PMID: 33162847]
  19. Pain Pract. 2012 Nov;12(8):602-9 [PMID: 22429694]
  20. Pain. 2006 Dec 15;126(1-3):272-9 [PMID: 16926068]
  21. BMJ. 2021 Mar 29;372:n71 [PMID: 33782057]
  22. J Gen Intern Med. 2015 Jul;30(7):979-91 [PMID: 25693651]
  23. Psychol Res Behav Manag. 2023 Mar 05;16:611-617 [PMID: 36911045]
  24. Lancet Child Adolesc Health. 2019 Dec;3(12):899-916 [PMID: 31606322]
  25. Rehabil Psychol. 2013 Feb;58(1):111-115 [PMID: 23438008]
  26. J Nerv Ment Dis. 2015 Aug;203(8):632-40 [PMID: 26153889]
  27. Lancet. 2007 Oct 20;370(9596):1453-7 [PMID: 18064739]
  28. Suicide Life Threat Behav. 2014 Dec;44(6):698-709 [PMID: 24816132]
  29. Gen Hosp Psychiatry. 2015 Sep-Oct;37(5):434-40 [PMID: 26112358]
  30. J Anesth. 2022 Jun;36(3):332-334 [PMID: 35107662]
  31. Pain Res Manag. 2021 Feb 22;2021:6617075 [PMID: 33680223]
  32. Clin J Pain. 2016 Apr;32(4):292-301 [PMID: 26295378]
  33. Pain Physician. 2021 Dec;24(8):E1299-E1306 [PMID: 34793657]
  34. PLoS One. 2022 Apr 29;17(4):e0267844 [PMID: 35486582]
  35. BMC Public Health. 2013 Dec 24;13:1229 [PMID: 24365383]
  36. J Pain Res. 2021 Aug 24;14:2629-2639 [PMID: 34466030]
  37. Curr Pain Headache Rep. 2014;18(8):435 [PMID: 24916035]
  38. Pain Physician. 2014 May-Jun;17(3):E359-67 [PMID: 24850117]
  39. Clin J Pain. 2014 Jun;30(6):463-71 [PMID: 24281291]
  40. Psychol Bull. 2020 Dec;146(12):1117-1145 [PMID: 33119344]
  41. Int J Environ Res Public Health. 2023 Feb 14;20(4): [PMID: 36834037]
  42. Clin J Pain. 2017 Jan;33(1):21-27 [PMID: 26905572]
  43. Eur J Pain. 2009 Sep;13(8):865-9 [PMID: 19010075]
  44. Arch Public Health. 2014 Nov 10;72(1):39 [PMID: 25810908]
  45. Psychiatry Investig. 2016 Nov;13(6):609-615 [PMID: 27909451]
  46. Scand J Pain. 2019 Jan 28;19(1):93-99 [PMID: 30205653]
  47. World J Psychiatry. 2022 Aug 19;12(8):1044-1060 [PMID: 36158305]
  48. Psychiatr Q. 2017 Dec;88(4):687-700 [PMID: 28091795]
  49. Psychol Res Behav Manag. 2020 Oct 29;13:855-858 [PMID: 33154680]
  50. J Pain. 2011 Oct;12(10):1032-9 [PMID: 21684217]
  51. Pain. 2022 Sep 1;163(9):e972-e984 [PMID: 34817439]
  52. JAMA. 2016 Dec 27;316(24):2627-2646 [PMID: 28027366]
  53. J Anaesthesiol Clin Pharmacol. 2013 Jan;29(1):76-82 [PMID: 23493638]
  54. Aust N Z J Psychiatry. 2015 Sep;49(9):803-11 [PMID: 25698809]
  55. J Pain. 2018 May;19(5):455-474 [PMID: 29198932]
  56. Aust N Z J Psychiatry. 2002 Dec;36(6):733-42 [PMID: 12406115]
  57. Pain. 2004 Sep;111(1-2):201-8 [PMID: 15327824]
  58. Clin J Pain. 2008 Mar-Apr;24(3):204-10 [PMID: 18287825]
  59. J Addict Med. 2020 Dec;14(6):e330-e336 [PMID: 32487945]
  60. Mayo Clin Proc. 2016 Jul;91(7):955-70 [PMID: 27344405]
  61. Korean J Pain. 2022 Apr 1;35(2):209-223 [PMID: 35354684]
  62. Syst Rev. 2022 Jan 8;11(1):8 [PMID: 34998432]
  63. Front Psychiatry. 2021 Sep 16;12:690130 [PMID: 34603096]
  64. Ann Intern Med. 2018 Oct 2;169(7):448-455 [PMID: 30208405]
  65. Evid Based Complement Alternat Med. 2015;2015:495684 [PMID: 26823672]
  66. Healthcare (Basel). 2023 Mar 27;11(7): [PMID: 37046882]
  67. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt B):269-280 [PMID: 28847525]

Word Cloud

Created with Highcharts 10.0.0painchronicprevalenceSBsuicidalstudiesincludedreviewSIindividualsqualitylifesystematicfactorssuicidemeta-analysispopulationpooledleadingadditionmeaningideationattemptSA4observationalmethodologicalusing17highbehaviorObjective:Chroniccausedisabilityseverelyimpairingindividual'sdailyactivityconditionmaycontributethoughtsneuropsychologicalimpairmentsperceivedlackpain-relatedcatastrophizingaimedcomprehensivelyinvestigateassociatedbehaviorsSBsincludingcompleteMethods:FiveelectronicdatabasessearchedOctober2022investigatingassessedStrengtheningReportingObservationalStudiesEpidemiologySTROBEstatementconductedquantifycommand"Metaprop"usedSTATA/MP16explainingassociationidentifiedregressionanalysisinvestigatedResults:total19 = 3312343lifetime2890%95%confidenceinterval954126%1083%57230%respectivelymixedsamplecomprisingvariousconditionsImportantlypast2-week2587%18093450%optimalvalidatedassessmenttoolslackingPotentialprotectivecopingself-efficacyolderagecertainrace/ethnicitygroupsmarriageConclusion:demonstratedSpecificallyaround1withinlast2 weeksHoweverconsiderableheterogeneityPrevalencepatientspain:demoralization

Similar Articles

Cited By